A novel combination therapy designed to enhance cognitive function, improve attentional control, and support wakefulness in ADHD and narcolepsy.

What We Do

Modamane is a UK-based biotechnology company developing patented therapies that combine established pharmaceuticals with neurotrophic biological compounds. Our lead innovation is a patent-pending combination of modafinil and Lion’s Mane extract, designed to deliver a dual-mechanism approach to cognitive enhancement and wakefulness support.

Why Our Approach Is Different

A differentiated, synergistic mechanism:

• Modafinil enhances alertness, attention, and wakefulness

• Lion’s Mane promotes neurotrophic activity and NGF stimulation

• Combined, they form a unique therapeutic strategy not available in current treatments

This therapy opens new avenues for pharmaceutical development across ADHD, narcolepsy, and broader cognitive-function indications.

Opportunities for Collaboration

We are actively seeking partnerships with:

• Pharmaceutical manufacturers

• Biotech companies

• Digital therapeutics platforms

• Clinical research organisations

We offer flexible collaboration structures, including licensing, co-development, and territory-exclusive agreements, centred around our evolving intellectual property portfolio.